Quetiapine: Uses, Dosage & Side Effects
Atypical antipsychotic for schizophrenia, bipolar disorder and major depression
Quetiapine is an atypical (second-generation) antipsychotic medication used to treat schizophrenia, bipolar disorder (manic and depressive episodes), and as adjunctive therapy for major depressive disorder. It works by modulating serotonin and dopamine activity in the brain. Quetiapine is available in immediate-release and extended-release formulations and requires a prescription in all countries. Common side effects include drowsiness, weight gain, and dizziness. Regular metabolic monitoring is recommended during treatment.
Quick Facts
Key Takeaways
- Quetiapine is a versatile atypical antipsychotic approved for schizophrenia, bipolar disorder (mania and depression), and adjunctive treatment of major depressive disorder.
- Extended-release tablets should be swallowed whole (not crushed or chewed) and taken once daily, preferably at bedtime or at least one hour before meals.
- Common side effects include drowsiness, weight gain, dizziness, and metabolic changes (elevated blood sugar, cholesterol, and triglycerides) requiring regular monitoring.
- Never stop quetiapine abruptly as this can cause withdrawal symptoms; always taper gradually under medical supervision over at least 1–2 weeks.
- Quetiapine carries a black box warning for increased suicidality risk in young adults under 25 and is not approved for dementia-related psychosis in elderly patients.
What Is Quetiapine and What Is It Used For?
Quick Answer: Quetiapine is an atypical antipsychotic medication that affects serotonin, dopamine, and other neurotransmitters in the brain. It is primarily prescribed for schizophrenia, bipolar disorder, and as an add-on treatment for major depressive disorder (MDD).
Quetiapine belongs to a class of medications known as second-generation (atypical) antipsychotics. Originally developed and marketed under the brand name Seroquel by AstraZeneca, quetiapine has been available in generic forms since its patent expired. It is one of the most widely prescribed antipsychotic medications globally, with over 20 million prescriptions dispensed annually in the United States alone, according to FDA data.
The medication exerts its therapeutic effects through a complex pharmacological profile. Quetiapine acts as an antagonist at multiple neurotransmitter receptors, including serotonin 5-HT2A receptors, dopamine D1 and D2 receptors, histamine H1 receptors, and adrenergic alpha-1 and alpha-2 receptors. Its active metabolite, norquetiapine, also inhibits the norepinephrine transporter (NET), which is believed to contribute significantly to its antidepressant properties. This broad receptor binding profile distinguishes quetiapine from both older typical antipsychotics and many other atypical antipsychotics.
Quetiapine is approved for several psychiatric conditions. For schizophrenia, it helps manage positive symptoms (hallucinations, delusions, disorganized thinking) and negative symptoms (social withdrawal, flat affect, lack of motivation). In bipolar disorder, quetiapine is effective for both manic episodes (elevated mood, hyperactivity, impaired judgment, agitation) and depressive episodes (persistent sadness, guilt, low energy, sleep disturbance). For major depressive disorder, the extended-release formulation is approved as adjunctive therapy alongside conventional antidepressants when initial treatment has been insufficient.
Quetiapine is available in two formulations: immediate-release (IR) tablets for twice-daily dosing and extended-release (XR) tablets for once-daily dosing. The extended-release formulation provides a more gradual drug release, which may improve tolerability and simplify dosing. Your doctor will select the most appropriate formulation based on your diagnosis, treatment goals, and individual response. It is important to continue taking quetiapine even when you feel better, unless your doctor instructs you otherwise, as discontinuation can lead to relapse of the underlying condition.
What Should You Know Before Taking Quetiapine?
Quick Answer: Before starting quetiapine, inform your doctor about all existing medical conditions, current medications, and whether you are pregnant or breastfeeding. Several contraindications and warnings apply, including risks related to heart conditions, diabetes, liver disease, and seizure history.
Contraindications
Quetiapine must not be taken if you have a known allergy (hypersensitivity) to quetiapine or any of its inactive ingredients. Additionally, quetiapine is contraindicated with certain medications due to dangerous drug interactions. Do not take quetiapine if you are currently using any of the following:
- HIV protease inhibitors (e.g., ritonavir, indinavir, nelfinavir, saquinavir) — these potent CYP3A4 inhibitors can dramatically increase quetiapine levels in the blood, leading to severe toxicity
- Azole antifungals (e.g., ketoconazole, itraconazole, voriconazole) — strong inhibitors of quetiapine metabolism
- Erythromycin or clarithromycin — macrolide antibiotics that inhibit CYP3A4 and raise quetiapine concentrations
- Nefazodone — an antidepressant that significantly inhibits quetiapine metabolism
If you are currently taking any of these medications, speak with your doctor before starting quetiapine. Your doctor may need to choose an alternative treatment or adjust your medication regimen.
Warnings and Precautions
Inform your doctor before taking quetiapine if any of the following conditions apply to you:
- Heart problems: A personal or family history of abnormal heart rhythm (arrhythmia), weak heart muscle (cardiomyopathy), heart inflammation, or any condition affecting the QT interval on ECG. Quetiapine can affect cardiac electrical activity.
- Low blood pressure: Quetiapine can cause orthostatic hypotension (a sudden drop in blood pressure upon standing), especially during initial dose titration, increasing the risk of dizziness, lightheadedness, and falls.
- History of stroke: Particularly important for elderly patients. Antipsychotics, including quetiapine, are associated with an increased risk of cerebrovascular events in certain populations.
- Liver disease: Impaired liver function can alter quetiapine metabolism, potentially requiring dose adjustment. Your doctor may start you on a lower dose and titrate more slowly.
- Seizure disorder (epilepsy): Quetiapine may lower the seizure threshold. If you have a history of seizures, your doctor should be informed before prescribing.
- Diabetes or metabolic risk: Quetiapine can elevate blood glucose, triglycerides, and cholesterol levels. Regular metabolic monitoring is essential, particularly if you have diabetes or risk factors for metabolic syndrome.
- Low white blood cell count: Quetiapine can cause leukopenia and, rarely, agranulocytosis. Prior history of drug-induced blood disorders increases risk.
- Dementia in elderly: Quetiapine is not approved for dementia-related psychosis. Elderly patients with dementia treated with antipsychotics have an increased risk of death and cerebrovascular adverse events.
- Parkinson's disease: Antipsychotic medications, including quetiapine, may worsen parkinsonian symptoms due to dopamine receptor blockade.
- Blood clots (thromboembolism): Antipsychotics have been associated with an increased risk of venous thromboembolism, including deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Sleep apnea: Quetiapine's sedative effects may worsen obstructive sleep apnea, especially when combined with other CNS depressants.
- Urinary retention or prostatic hyperplasia: Quetiapine's anticholinergic properties may exacerbate conditions involving difficulty urinating or incomplete bladder emptying.
- History of substance abuse: Quetiapine's sedative and anxiolytic effects may carry some misuse potential. Report any past substance use disorders to your prescriber.
- Neuroleptic malignant syndrome (NMS): A rare but life-threatening combination of fever, severe muscle rigidity, sweating, and reduced consciousness. This requires emergency medical treatment.
- Tardive dyskinesia: Uncontrollable movements, especially of the face and tongue, which may become permanent if not detected early.
- Severe cardiac symptoms: Rapid irregular heartbeat at rest, palpitations, difficulty breathing, chest pain, or unexplained fatigue may indicate cardiac arrhythmia requiring urgent evaluation.
- Priapism: A prolonged and painful erection lasting more than 4 hours requires emergency treatment to prevent permanent damage.
- Severe skin reactions: Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), or drug reaction with eosinophilia and systemic symptoms (DRESS) — widespread rash with blisters, skin peeling, fever, or swollen lymph nodes.
If you are being treated for depression, you may sometimes have thoughts of self-harm or suicide. These thoughts may increase when first starting the medication, as antipsychotics and antidepressants typically require at least 2 weeks before reaching full therapeutic effect. Such thoughts may also increase if you suddenly stop the medication. Clinical data indicate that the risk of suicidal thoughts and behavior is higher in young adults under 25 with depression.
Contact your doctor immediately or go to the nearest emergency department if you have thoughts of self-harm or suicide. It may be helpful to tell a relative or close friend that you are feeling depressed and ask them to read this information.
Pregnancy and Breastfeeding
Quetiapine should not be used during pregnancy unless the potential benefit clearly justifies the potential risk to the fetus. If you are pregnant, think you may be pregnant, or are planning to become pregnant, consult your doctor before using this medication. Your healthcare provider will carefully weigh the risks of untreated psychiatric illness against the potential risks of medication exposure.
Newborns exposed to antipsychotics (including quetiapine) during the third trimester may experience withdrawal symptoms after delivery, including tremor, muscle rigidity and/or weakness, drowsiness, agitation, breathing difficulties, and feeding problems. If your baby develops any of these symptoms, contact your healthcare provider promptly.
Quetiapine should not be used during breastfeeding. The medication is excreted in breast milk and could affect the nursing infant. Discuss alternative feeding options with your doctor if you require quetiapine treatment postpartum.
Driving and Operating Machinery
Quetiapine can cause significant drowsiness, especially at the start of treatment and during dose increases. Do not drive, operate heavy machinery, or engage in activities requiring full mental alertness until you know how quetiapine affects you personally. The sedative effects may diminish over time as your body adjusts, but individual responses vary considerably.
Food, Alcohol, and Grapefruit
Extended-release quetiapine tablets should be taken on an empty stomach, at least one hour before a meal, or at bedtime. Taking extended-release tablets with food significantly increases drug absorption and may alter the intended release profile. Be cautious with alcohol, as the combination with quetiapine can intensify drowsiness and impairment. Avoid grapefruit juice during quetiapine treatment, as grapefruit inhibits CYP3A4 enzymes and can increase quetiapine blood levels, raising the risk of side effects.
Quetiapine use may cause false-positive results on certain urine drug screening tests for methadone or tricyclic antidepressants (TCAs). If you need to undergo drug testing, inform the testing laboratory that you are taking quetiapine so that a more specific confirmatory test can be performed if necessary.
How Does Quetiapine Interact with Other Drugs?
Quick Answer: Quetiapine is metabolized primarily by the liver enzyme CYP3A4. Strong inhibitors of this enzyme can dangerously increase quetiapine levels, while strong inducers can reduce its effectiveness. Always inform your doctor about all medications, supplements, and herbal products you are taking.
Drug interactions with quetiapine can range from clinically insignificant to potentially life-threatening. Quetiapine undergoes extensive hepatic metabolism, predominantly through the cytochrome P450 3A4 (CYP3A4) enzyme system. Medications that inhibit or induce CYP3A4 can significantly alter quetiapine plasma concentrations, affecting both efficacy and safety. Additionally, quetiapine's pharmacological profile means it can interact pharmacodynamically with other CNS-active medications.
Major Interactions (Contraindicated or Avoid)
The following medications should not be taken concurrently with quetiapine due to the risk of serious adverse effects:
| Drug / Drug Class | Interaction Type | Clinical Effect |
|---|---|---|
| HIV protease inhibitors (ritonavir, indinavir) | Strong CYP3A4 inhibitor | Markedly increased quetiapine levels; risk of severe toxicity |
| Azole antifungals (ketoconazole, itraconazole) | Strong CYP3A4 inhibitor | Significantly increased quetiapine levels; risk of QT prolongation |
| Macrolide antibiotics (erythromycin, clarithromycin) | CYP3A4 inhibitor | Increased quetiapine levels; enhanced sedation and side effects |
| Nefazodone | Strong CYP3A4 inhibitor | Substantially increased quetiapine levels; risk of oversedation |
Moderate Interactions (Use with Caution)
The following medications require careful monitoring or dose adjustments when used together with quetiapine:
| Drug / Drug Class | Interaction Type | Clinical Effect |
|---|---|---|
| Phenytoin, Carbamazepine | Strong CYP3A4 inducers | Substantially reduced quetiapine levels; may require 5-fold dose increase |
| Barbiturates | CYP3A4 inducer / CNS depressant | Reduced quetiapine levels and additive sedation |
| Thioridazine | Antipsychotic combination | Increased quetiapine clearance; additive QT prolongation risk |
| Lithium | Pharmacodynamic | Enhanced therapeutic effect but increased risk of neurological side effects |
| Antidepressants (SSRIs, SNRIs) | Serotonergic interaction | Risk of serotonin syndrome: involuntary muscle contractions, agitation, hallucinations, excessive sweating, tremor, hyperthermia |
| Antihypertensives | Pharmacodynamic | Additive hypotensive effect; increased risk of fainting |
| QT-prolonging drugs (diuretics, certain antibiotics) | Pharmacodynamic | Additive QT prolongation risk; monitor electrolytes (potassium, magnesium) |
| Anticholinergic drugs | Pharmacodynamic | Additive anticholinergic effects: constipation, urinary retention, dry mouth, confusion |
Always inform your doctor, pharmacist, or nurse about all medications you are currently taking, have recently taken, or might take, including over-the-counter medicines, herbal supplements (especially St. John's Wort, which induces CYP3A4), and dietary supplements. Do not start or stop any medication without consulting your healthcare provider first.
What Is the Correct Dosage of Quetiapine?
Quick Answer: Quetiapine dosage varies by condition and is individualized by your doctor. Typical maintenance doses range from 150 mg to 800 mg daily. Extended-release tablets are taken once daily, while immediate-release tablets are usually taken two to three times daily. Always follow your doctor's specific instructions.
Quetiapine dosing is highly individualized and depends on the condition being treated, patient age, hepatic function, and concomitant medications. The general principle is to start at a low dose and gradually increase (titrate) to the effective maintenance dose to minimize side effects, particularly sedation and orthostatic hypotension. The information below provides general dosing guidelines; your doctor will determine the most appropriate dose for your specific situation.
Adults
| Indication | Starting Dose | Titration | Maintenance Dose |
|---|---|---|---|
| Schizophrenia | 300 mg on Day 1 | Up to 600 mg on Day 2; adjust by 300 mg/day increments | 400–800 mg/day |
| Bipolar Mania | 300 mg on Day 1 | 600 mg on Day 2; adjust up to 800 mg by Day 3 | 400–800 mg/day |
| Bipolar Depression | 50 mg on Day 1 | 100 mg Day 2, 200 mg Day 3, 300 mg Day 4 | 300 mg/day |
| MDD (adjunctive) | 50 mg on Day 1–2 | 150 mg on Day 3 | 150–300 mg/day |
Extended-release tablets should be taken once daily, preferably in the evening or at bedtime. Swallow the tablets whole with water — do not split, crush, or chew them, as this disrupts the extended-release mechanism and can lead to an excessive initial dose. Take the medication on an empty stomach (at least one hour before a meal) or at bedtime as directed by your doctor.
Children and Adolescents
Quetiapine is not recommended for use in children and adolescents under 18 years of age. While some regulatory agencies have granted limited pediatric approvals for specific indications in certain regions, the safety and efficacy of quetiapine in this age group require careful evaluation. Clinical studies have shown that the side effect profile in children and adolescents includes all of the effects seen in adults, with some effects occurring more frequently, including elevated prolactin levels, increased appetite, vomiting, elevated blood pressure, and abnormal muscle movements. The decision to use quetiapine in younger patients must be made by a qualified specialist with experience in pediatric psychopharmacology.
Elderly Patients
Dose adjustment may be necessary in elderly patients. Quetiapine clearance is reduced by approximately 40% in the elderly, and sensitivity to side effects (particularly orthostatic hypotension, sedation, and anticholinergic effects) is generally increased. Treatment should be initiated at a lower dose and titrated more slowly than in younger adults. Quetiapine should not be used in elderly patients with dementia-related psychosis due to an increased risk of mortality and cerebrovascular events demonstrated in clinical studies with atypical antipsychotics.
Hepatic Impairment
Quetiapine is extensively metabolized by the liver. Patients with hepatic impairment may require a lower starting dose (typically 25 mg/day) with slower titration increments of 25–50 mg/day until an effective dose is reached. Liver function should be monitored periodically during treatment.
Missed Dose
If you forget to take a dose, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a forgotten dose, as this increases the risk of excessive sedation and other side effects.
Overdose
If you take more quetiapine than prescribed, or if a child accidentally ingests the medication, contact your nearest emergency department or poison control center immediately. Symptoms of overdose may include excessive drowsiness, severe dizziness, rapid or irregular heartbeat, low blood pressure, and in severe cases, loss of consciousness. Bring the medication packaging with you to assist healthcare providers in determining the amount ingested. There is no specific antidote for quetiapine; treatment is supportive and symptomatic, with close cardiovascular monitoring.
What Are the Side Effects of Quetiapine?
Quick Answer: Like all medications, quetiapine can cause side effects. The most common include drowsiness, dizziness, dry mouth, headache, and weight gain. Metabolic side effects (elevated blood sugar, cholesterol, triglycerides) require regular monitoring. Serious but rare side effects include neuroleptic malignant syndrome, tardive dyskinesia, and cardiac arrhythmias.
Quetiapine's broad receptor binding profile accounts for its wide range of potential side effects. The likelihood and severity of side effects often depend on the dose, duration of treatment, and individual patient factors. Many common side effects, particularly drowsiness, tend to diminish over time as the body adjusts to the medication. Your doctor should weigh the benefits of treatment against the potential risks and monitor you regularly for adverse effects.
Very Common
Affects more than 1 in 10 patients
- Dizziness (which may lead to falls)
- Headache
- Dry mouth
- Drowsiness / somnolence (especially early in treatment; may lead to falls)
- Withdrawal symptoms upon discontinuation (insomnia, nausea, headache, diarrhea, vomiting, irritability)
- Weight gain
- Abnormal muscle movements (difficulty initiating movement, tremor, restlessness, muscle stiffness)
- Elevated triglycerides and total cholesterol
Common
Affects 1 in 10 to 1 in 100 patients
- Rapid heart rate (tachycardia), palpitations
- Constipation, indigestion (dyspepsia)
- Weakness, fatigue
- Swelling of arms or legs (peripheral edema)
- Orthostatic hypotension (blood pressure drop upon standing; may lead to falls)
- Elevated blood sugar (hyperglycemia)
- Blurred vision
- Abnormal dreams, nightmares
- Increased appetite
- Irritability
- Speech and language disturbances
- Suicidal thoughts, worsening depression
- Shortness of breath (dyspnea)
- Vomiting (especially in elderly patients)
- Fever
- Altered thyroid hormone levels
- Decreased blood cell counts
- Elevated liver enzymes
- Elevated prolactin (which can rarely lead to breast swelling, unexpected lactation, or menstrual irregularities)
Uncommon
Affects 1 in 100 to 1 in 1,000 patients
- Seizures / convulsions
- Allergic reactions (raised lumps, skin swelling, swelling around the mouth)
- Restless legs syndrome (RLS)
- Difficulty swallowing (dysphagia)
- Tardive dyskinesia (involuntary movements, especially of face and tongue)
- Sexual dysfunction
- Diabetes mellitus (new onset)
- QT prolongation on ECG
- Bradycardia (slow heart rate), especially early in treatment
- Difficulty urinating (urinary retention)
- Syncope / fainting (may lead to falls)
- Nasal congestion
- Decreased red blood cells (anemia)
- Low sodium levels (hyponatremia)
- Worsening diabetes
- Confusion
Rare
Affects 1 in 1,000 to 1 in 10,000 patients
- Neuroleptic malignant syndrome (NMS): fever, severe muscle rigidity, sweating, reduced consciousness
- Jaundice (yellowing of skin and eyes)
- Hepatitis (liver inflammation)
- Priapism (prolonged painful erection)
- Galactorrhea (unexpected breast milk production)
- Menstrual irregularities
- Venous thromboembolism (DVT, pulmonary embolism)
- Sleepwalking, sleep-eating, sleep-talking
- Hypothermia (low body temperature)
- Pancreatitis
- Metabolic syndrome
- Agranulocytosis (dangerously low white blood cells)
- Intestinal obstruction
- Elevated creatine phosphokinase (CPK)
Very Rare / Frequency Unknown
Affects fewer than 1 in 10,000 patients or frequency not established
- Severe skin reactions: Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN)
- Anaphylactic reaction (severe allergic reaction with breathing difficulties or shock)
- Angioedema (sudden swelling around eyes, lips, and throat)
- DRESS syndrome (drug reaction with eosinophilia and systemic symptoms)
- AGEP (acute generalized exanthematous pustulosis)
- Erythema multiforme (irregular red patches on skin)
- SIADH (syndrome of inappropriate antidiuretic hormone secretion)
- Rhabdomyolysis (muscle fiber breakdown)
- Cardiomyopathy (heart muscle disease)
- Myocarditis (heart muscle inflammation)
- Vasculitis (blood vessel inflammation)
- Stroke (reported in elderly dementia patients)
Some side effects are only detectable through blood tests. Your doctor may periodically check your blood for changes in lipid levels (triglycerides, cholesterol), blood sugar (glucose), thyroid hormone levels, liver enzymes, blood cell counts, sodium levels, creatine phosphokinase, and prolactin levels. It is important to attend all scheduled blood tests and follow-up appointments to ensure your safety during treatment.
How Should You Store Quetiapine?
Quick Answer: Store quetiapine at room temperature, away from moisture and direct light. Keep all medications out of reach of children. Do not use after the expiration date.
Quetiapine tablets should be stored at room temperature (below 25°C / 77°F) in a dry place, protected from excessive heat, moisture, and direct sunlight. No special storage conditions are required beyond these standard recommendations. Keep the tablets in their original blister packaging until use.
Store all medications out of the sight and reach of children and pets. If a child accidentally ingests quetiapine, seek emergency medical attention immediately, as even small doses can be dangerous to young children.
Do not use quetiapine after the expiration date printed on the packaging (after "EXP"). The expiration date refers to the last day of that month. Do not dispose of medications by flushing them down the toilet or throwing them in household waste, as pharmaceutical contamination of water supplies is an environmental concern. Return unused or expired medications to a pharmacy or follow local guidelines for safe medication disposal.
What Does Quetiapine Contain?
Quick Answer: The active ingredient is quetiapine (as quetiapine fumarate). Inactive ingredients vary by manufacturer and formulation but commonly include lactose monohydrate, hypromellose, sodium chloride, povidone, talc, and magnesium stearate.
Each quetiapine tablet contains the active substance quetiapine (as quetiapine fumarate). The amount of quetiapine per tablet corresponds to the labeled strength (25 mg, 50 mg, 100 mg, 150 mg, 200 mg, 300 mg, or 400 mg).
The inactive ingredients (excipients) in quetiapine tablets serve various pharmaceutical functions and may vary between manufacturers and formulations. Common excipients in quetiapine extended-release tablets include:
- Tablet core: Lactose monohydrate, hypromellose, sodium chloride, povidone K-30, talc, magnesium stearate, and silicified microcrystalline cellulose (in some strengths).
- Film coating: Polyvinyl alcohol (E1203), titanium dioxide (E171), talc (E553b), macrogol/PEG (E1521), and iron oxide pigments (E172, varying by strength for color differentiation).
Lactose: Quetiapine tablets contain lactose monohydrate. If you have been diagnosed with lactose intolerance or a rare hereditary condition of galactose intolerance, contact your doctor before taking this medication.
Sodium: Quetiapine extended-release tablets contain less than 1 mmol (23 mg) sodium per tablet and are considered essentially sodium-free.
Frequently Asked Questions About Quetiapine
Quetiapine is an atypical antipsychotic used to treat schizophrenia, bipolar disorder (both manic and depressive episodes), and as adjunctive therapy for major depressive disorder (MDD) when initial antidepressant treatment has been insufficient. It works by modulating serotonin, dopamine, histamine, and norepinephrine activity in the brain. Quetiapine is one of the most widely prescribed antipsychotic medications worldwide and is available in both immediate-release and extended-release formulations.
The most common side effects (affecting more than 1 in 10 patients) include drowsiness, dizziness, dry mouth, headache, weight gain, abnormal muscle movements (tremor, restlessness, stiffness), and elevated blood lipids (triglycerides and cholesterol). Drowsiness is particularly noticeable when starting treatment and often improves over time. Your doctor should regularly monitor your metabolic parameters, including weight, blood sugar, and lipid levels throughout treatment.
No, you should never stop quetiapine abruptly. Sudden discontinuation can cause withdrawal symptoms including insomnia, nausea, headache, diarrhea, vomiting, dizziness, and irritability. These symptoms can begin within days of stopping the medication. Your doctor should gradually reduce your dose over a period of at least 1–2 weeks. Always consult your healthcare provider before making any changes to your quetiapine regimen.
Yes, weight gain is a common side effect of quetiapine. Studies indicate that patients may gain an average of 2–5 kg during the first year of treatment, though individual variation is significant. The weight gain is partly related to quetiapine's antihistamine activity, which increases appetite, as well as metabolic effects on glucose and lipid metabolism. Regular monitoring of weight and metabolic parameters (blood glucose, HbA1c, lipid panel) is recommended. Your doctor may suggest dietary modifications and exercise to help manage weight during treatment.
Quetiapine should only be used during pregnancy when the potential benefits clearly outweigh the risks to the fetus. Newborns exposed to antipsychotics during the third trimester may experience withdrawal symptoms including tremor, muscle rigidity, weakness, drowsiness, agitation, breathing difficulties, and feeding problems after delivery. If you are pregnant, planning a pregnancy, or discover you are pregnant while taking quetiapine, discuss your treatment options with your doctor immediately. Do not stop quetiapine abruptly without medical guidance, as untreated psychiatric illness also carries risks during pregnancy.
While quetiapine has sedative properties due to its histamine H1 receptor antagonism and is sometimes prescribed off-label at low doses (25–100 mg) for insomnia, this use is not officially approved by most regulatory agencies. Using quetiapine for insomnia carries risks of metabolic side effects (weight gain, elevated blood sugar and lipids), movement disorders, and other adverse effects. Evidence-based insomnia treatments, including cognitive behavioral therapy for insomnia (CBT-I) and approved sleep medications, should generally be considered first. Any off-label use should be carefully discussed with and monitored by your healthcare provider.
References
This article is based on the following peer-reviewed sources, international guidelines, and regulatory documents. All medical claims adhere to Evidence Level 1A (systematic reviews and randomized controlled trials) where available.
- European Medicines Agency (EMA). Seroquel (quetiapine) — Summary of Product Characteristics (SmPC). European Medicines Agency. Last updated 2025.
- U.S. Food and Drug Administration (FDA). Seroquel (quetiapine fumarate) Prescribing Information. FDA Label. Revised 2024.
- World Health Organization (WHO). WHO Model List of Essential Medicines — 23rd List (2023). WHO Technical Report Series. Geneva: WHO; 2023.
- National Institute for Health and Care Excellence (NICE). Psychosis and schizophrenia in adults: prevention and management (CG178). NICE Guidelines. Updated 2024.
- British Association for Psychopharmacology (BAP). Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the BAP. J Psychopharmacol. 2020;34(1):3–78.
- Leucht S, Cipriani A, Spineli L, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382(9896):951–962. doi:10.1016/S0140-6736(13)60733-3
- Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet. 2019;394(10202):939–951. doi:10.1016/S0140-6736(19)31135-3
- Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20(2):97–170.
- British National Formulary (BNF). Quetiapine — Drug Monograph. NICE BNF. Accessed January 2026.
- Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. 5th ed. Cambridge University Press; 2021.
Editorial Team
This article was produced by the iMedic Medical Editorial Team and reviewed by board-certified physicians specializing in psychiatry and clinical pharmacology. Our editorial process follows international medical standards and the GRADE evidence framework.
iMedic Medical Editorial Team — Licensed physicians with specialization in psychiatry, psychopharmacology, and clinical pharmacology.
iMedic Medical Review Board — Independent panel following WHO, EMA, FDA, NICE, and BAP guidelines. All content fact-checked against primary sources.
Level 1A evidence based on systematic reviews, meta-analyses, and randomized controlled trials. GRADE evidence framework applied.
No pharmaceutical company funding. No advertising. No conflicts of interest. Editorially independent medical information.